- Home
- PCYO vs ELTX Comparison
PCYO vs ELTX Comparison
Compare PCYO & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCYO | ELTX |
|---|---|---|
| Founded | 1976 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 242.8M | 209.9M |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PCYO | ELTX |
|---|---|---|
| Price | $10.37 | $10.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 46.9K | ★ 126.8K |
| Earning Date | 04-08-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.50 | ★ 39.29 |
| EPS | ★ 0.19 | N/A |
| Revenue | $1,227,787.00 | ★ $2,301,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $52.95 | ★ N/A |
| Revenue Growth | ★ 171.54 | N/A |
| 52 Week Low | $9.65 | $4.60 |
| 52 Week High | $12.16 | $14.93 |
Technical Indicators
Market Signals| Indicator | PCYO | ELTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 48.39 |
| Support Level | $9.84 | $9.84 |
| Resistance Level | $10.62 | $11.12 |
| Average True Range (ATR) | 0.31 | 0.97 |
| MACD | 0.03 | -0.23 |
| Stochastic Oscillator | 59.90 | 26.22 |
Price Performance
Historical ComparisonAbout PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.